Cell and gene therapies offer hope for previously untreatable diseases, with viral vectors currently favored as the primary gene delivery method. To meet patient needs, reliable and cost-effective ...

Cell therapy production processes tend to evolve as the product moves through clinical development towards approval. While such changes may streamline testing, they can be a challenge when it comes to ...

Mesenchymal stromal cell (MSC) therapies continue to show promise across a wide range of indications, but translating early scientific success into scalable, reproducible, and commercially viable ...

One of the biggest challenges in implementing energy and climate technologies is actually scaling them up to deploy. While scale-up has largely been the domain of industrial R&D teams, advances in ...